ID   AMGO2_HUMAN             Reviewed;         522 AA.
AC   Q86SJ2; Q4VBP6; Q7Z4A0; Q96CN8;
DT   21-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   28-JUN-2023, entry version 175.
DE   RecName: Full=Amphoterin-induced protein 2;
DE   AltName: Full=AMIGO-2;
DE   AltName: Full=Alivin-1;
DE   AltName: Full=Differentially expressed in gastric adenocarcinomas;
DE            Short=DEGA;
DE   Flags: Precursor;
GN   Name=AMIGO2 {ECO:0000312|EMBL:AAH47595.1};
GN   Synonyms=ALI1 {ECO:0000312|EMBL:BAC81189.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000312|EMBL:AAO48946.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fibrosarcoma {ECO:0000269|PubMed:12629050};
RX   PubMed=12629050; DOI=10.1083/jcb.200209074;
RA   Kuja-Panula J., Kiiltomaeki M., Yamashiro T., Rouhiainen A., Rauvala H.;
RT   "AMIGO, a transmembrane protein implicated in axon tract development,
RT   defines a novel protein family with leucine-rich repeats.";
RL   J. Cell Biol. 160:963-973(2003).
RN   [2] {ECO:0000312|EMBL:BAC81189.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain {ECO:0000312|EMBL:BAC81189.1};
RX   PubMed=12843293; DOI=10.1523/jneurosci.23-13-05887.2003;
RA   Ono T., Sekino-Suzuki N., Kikkawa Y., Yonekawa H., Kawashima S.;
RT   "Alivin 1, a novel neuronal activity-dependent gene, inhibits apoptosis and
RT   promotes survival of cerebellar granule neurons.";
RL   J. Neurosci. 23:5887-5896(2003).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAR83271.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=15107827; DOI=10.1038/sj.onc.1207681;
RA   Rabenau K.E., O'Toole J.M., Bassi R., Kotanides H., Witte L., Ludwig D.L.,
RA   Pereira D.S.;
RT   "DEGA/AMIGO-2, a leucine-rich repeat family member, differentially
RT   expressed in human gastric adenocarcinoma: effects on ploidy, chromosomal
RT   stability, cell adhesion/migration and tumorigenicity.";
RL   Oncogene 23:5056-5067(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Stomach;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5] {ECO:0000312|EMBL:AAH47595.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis {ECO:0000312|EMBL:AAH47595.1}, and Uterus
RC   {ECO:0000312|EMBL:AAH14103.2};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
CC   -!- FUNCTION: Required for depolarization-dependent survival of cultured
CC       cerebellar granule neurons. May mediate homophilic as well as
CC       heterophilic cell-cell interaction with AMIGO1 or AMIGO3. May
CC       contribute to signal transduction through its intracellular domain. May
CC       be required for tumorigenesis of a subset of gastric adenocarcinomas.
CC   -!- SUBUNIT: Binds itself as well as AMIGO1 and AMIGO3. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q86SJ2; O00555: CACNA1A; NbExp=2; IntAct=EBI-3866830, EBI-766279;
CC       Q86SJ2; Q6PL24: TMED8; NbExp=3; IntAct=EBI-3866830, EBI-11603430;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I
CC       membrane protein {ECO:0000250}. Nucleus {ECO:0000250}. Note=Associated
CC       with nucleus as well as plasma membrane. Restricted to somata of
CC       cerebellar as well as hippocampal neurons (By similarity).
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Highest levels in breast, ovary, cervix, and
CC       uterus. Lower levels in lung, colon, and rectum. Differentially
CC       expressed in 56% of thyroid, 57% of pancreatic and 45% of stomach
CC       cancers. {ECO:0000269|PubMed:15107827}.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. AMIGO family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY237005; AAO48946.1; -; mRNA.
DR   EMBL; AB079074; BAC81188.1; -; mRNA.
DR   EMBL; AB080610; BAC81189.1; -; mRNA.
DR   EMBL; AY454159; AAR83271.1; -; mRNA.
DR   EMBL; AL833007; CAH56293.1; -; mRNA.
DR   EMBL; BC014103; AAH14103.2; -; mRNA.
DR   EMBL; BC047595; AAH47595.1; -; mRNA.
DR   EMBL; BC095477; AAH95477.1; -; mRNA.
DR   CCDS; CCDS8751.1; -.
DR   RefSeq; NP_001137140.1; NM_001143668.1.
DR   RefSeq; NP_862830.1; NM_181847.4.
DR   RefSeq; XP_005268894.1; XM_005268837.3.
DR   AlphaFoldDB; Q86SJ2; -.
DR   SMR; Q86SJ2; -.
DR   BioGRID; 131497; 32.
DR   IntAct; Q86SJ2; 6.
DR   STRING; 9606.ENSP00000266581; -.
DR   GlyConnect; 1007; 4 N-Linked glycans (1 site).
DR   GlyCosmos; Q86SJ2; 8 sites, 4 glycans.
DR   GlyGen; Q86SJ2; 9 sites, 4 N-linked glycans (1 site).
DR   iPTMnet; Q86SJ2; -.
DR   PhosphoSitePlus; Q86SJ2; -.
DR   SwissPalm; Q86SJ2; -.
DR   BioMuta; AMIGO2; -.
DR   DMDM; 68052338; -.
DR   EPD; Q86SJ2; -.
DR   jPOST; Q86SJ2; -.
DR   MassIVE; Q86SJ2; -.
DR   MaxQB; Q86SJ2; -.
DR   PaxDb; Q86SJ2; -.
DR   PeptideAtlas; Q86SJ2; -.
DR   ProteomicsDB; 69596; -.
DR   Antibodypedia; 13397; 268 antibodies from 31 providers.
DR   DNASU; 347902; -.
DR   Ensembl; ENST00000266581.4; ENSP00000266581.4; ENSG00000139211.7.
DR   Ensembl; ENST00000429635.1; ENSP00000406020.1; ENSG00000139211.7.
DR   Ensembl; ENST00000550413.2; ENSP00000449034.1; ENSG00000139211.7.
DR   GeneID; 347902; -.
DR   KEGG; hsa:347902; -.
DR   MANE-Select; ENST00000550413.2; ENSP00000449034.1; NM_001370299.1; NP_001357228.1.
DR   UCSC; uc001rpk.4; human.
DR   AGR; HGNC:24073; -.
DR   CTD; 347902; -.
DR   DisGeNET; 347902; -.
DR   GeneCards; AMIGO2; -.
DR   HGNC; HGNC:24073; AMIGO2.
DR   HPA; ENSG00000139211; Low tissue specificity.
DR   MIM; 615690; gene.
DR   neXtProt; NX_Q86SJ2; -.
DR   OpenTargets; ENSG00000139211; -.
DR   PharmGKB; PA142672626; -.
DR   VEuPathDB; HostDB:ENSG00000139211; -.
DR   eggNOG; ENOG502R009; Eukaryota.
DR   GeneTree; ENSGT00950000183146; -.
DR   HOGENOM; CLU_030478_0_0_1; -.
DR   InParanoid; Q86SJ2; -.
DR   OMA; QKNMLNQ; -.
DR   OrthoDB; 3789698at2759; -.
DR   PhylomeDB; Q86SJ2; -.
DR   TreeFam; TF326838; -.
DR   PathwayCommons; Q86SJ2; -.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   Reactome; R-HSA-9013423; RAC3 GTPase cycle.
DR   SignaLink; Q86SJ2; -.
DR   BioGRID-ORCS; 347902; 22 hits in 1166 CRISPR screens.
DR   GenomeRNAi; 347902; -.
DR   Pharos; Q86SJ2; Tbio.
DR   PRO; PR:Q86SJ2; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q86SJ2; protein.
DR   Bgee; ENSG00000139211; Expressed in blood vessel layer and 188 other tissues.
DR   ExpressionAtlas; Q86SJ2; baseline and differential.
DR   Genevisible; Q86SJ2; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0007420; P:brain development; IBA:GO_Central.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; ISS:UniProtKB.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; ISS:UniProtKB.
DR   GO; GO:0043069; P:negative regulation of programmed cell death; ISS:UniProtKB.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 1.
DR   InterPro; IPR031283; AMIGO.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013151; Immunoglobulin.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   PANTHER; PTHR24368; AMPHOTERIN-INDUCED PROTEIN; 1.
DR   PANTHER; PTHR24368:SF209; AMPHOTERIN-INDUCED PROTEIN 2; 1.
DR   Pfam; PF00047; ig; 1.
DR   Pfam; PF13855; LRR_8; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00369; LRR_TYP; 5.
DR   SMART; SM00082; LRRCT; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 1.
DR   SUPFAM; SSF52058; L domain-like; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS51450; LRR; 7.
PE   1: Evidence at protein level;
KW   Cell adhesion; Cell membrane; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Leucine-rich repeat; Membrane; Nucleus;
KW   Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..39
FT                   /evidence="ECO:0000255"
FT   CHAIN           40..522
FT                   /note="Amphoterin-induced protein 2"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000014509"
FT   TOPO_DOM        40..398
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        399..419
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        420..522
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          40..68
FT                   /note="LRRNT"
FT   REPEAT          69..90
FT                   /note="LRR 1"
FT   REPEAT          94..115
FT                   /note="LRR 2"
FT   REPEAT          118..139
FT                   /note="LRR 3"
FT   REPEAT          142..163
FT                   /note="LRR 4"
FT   REPEAT          166..187
FT                   /note="LRR 5"
FT   REPEAT          193..214
FT                   /note="LRR 6"
FT   DOMAIN          228..284
FT                   /note="LRRCT"
FT   DOMAIN          289..379
FT                   /note="Ig-like C2-type"
FT                   /evidence="ECO:0000255"
FT   REGION          501..522
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        502..522
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        58
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        104
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        281
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        288
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        345
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        373
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        381
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        384
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        41..47
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        45..54
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        232..260
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        234..282
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        310..363
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
SQ   SEQUENCE   522 AA;  57934 MW;  20A86E3D82C05B9B CRC64;
     MSLRVHTLPT LLGAVVRPGC RELLCLLMIT VTVGPGASGV CPTACICATD IVSCTNKNLS
     KVPGNLFRLI KRLDLSYNRI GLLDSEWIPV SFAKLNTLIL RHNNITSIST GSFSTTPNLK
     CLDLSSNKLK TVKNAVFQEL KVLEVLLLYN NHISYLDPSA FGGLSQLQKL YLSGNFLTQF
     PMDLYVGRFK LAELMFLDVS YNRIPSMPMH HINLVPGKQL RGIYLHGNPF VCDCSLYSLL
     VFWYRRHFSS VMDFKNDYTC RLWSDSRHSR QVLLLQDSFM NCSDSIINGS FRALGFIHEA
     QVGERLMVHC DSKTGNANTD FIWVGPDNRL LEPDKEMENF YVFHNGSLVI ESPRFEDAGV
     YSCIAMNKQR LLNETVDVTI NVSNFTVSRS HAHEAFNTAF TTLAACVASI VLVLLYLYLT
     PCPCKCKTKR QKNMLHQSNA HSSILSPGPA SDASADERKA GAGKRVVFLE PLKDTAAGQN
     GKVRLFPSEA VIAEGILKST RGKSDSDSVN SVFSDTPFVA ST
//
